ITF Therapeutics
A Senior Manager, Quality Systems at ITF Therapeutics oversees the enterprise Quality Management System (QMS) for commercial pharmaceutical distribution operations, ensuring compliance with regulatory requirements and driving continuous improvement.
Headquarters
Concord, Massachusetts, United States
Company Size
1-10 employees
Founded
2024
ITF Therapeutics LLC is the United States affiliate of Italfarmaco S.p.A., founded in 2024 and based in Concord, MA. The company focuses on bringing therapeutic options to people living with rare diseases, most notably commercializing DUVYZAT (givinostat), an FDA‑approved HDAC inhibitor for Duchenne muscular dystrophy (DMD), in the U.S. market. ITF combines a flexible, entrepreneurial approach with the resources and legacy of its parent organization to deliver treatments, support programs, and educational resources for patients, clinicians, and researchers.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ITF Therapeutics.
57% above the average for this role
Quality Systems Development Manager
Intuitive
Associate Director, QMS (Quality Management Systems) & CSA (Computer Software Assurance)
Structure Therapeutics
Manager, Quality Systems
Zevra
Quality Management Systems Supervisor
LUXGRP
Manager, Quality Management Systems & Validations
Ocular Therapeutix
Senior Quality Systems Engineer
Philips